Clinical Trials in Ohio

Showing 8641-8660 of 20,938 trials

Development of the Virtual Unified Huntington's Disease Rating Scale

NCT05748288

The Huntington Study Group currently holds the registered trademark for the Unified Huntington's Disease Rating Scale. The UHDRS® is a research tool which has been developed by the HSG to provide a uniform assessment of the clinical features and course of HD. The UHDRS® has undergone extensive reliability and validity testing and has been used as a major outcome measure by the HSG in controlled clinical trials. The purpose of this research study is to determine if a standard HD assessment (the UHDRS®) is as reliable when conducted virtually as it is when conducted at an in-person visit (vUHDRS)

Huntington Disease

Huntington Study Group60 participantsStarted Sep 2022

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +14 more locations

UNKNOWN32 miles

Biomarkers of Acute Stroke in Clinic

NCT03897478

The proposed study will investigate the clinical use of the ISCDX test that may differentiate between diverse stroke etiologies as listed below: Aim 1: Differentiate between cardioembolic and large artery atherosclerotic ischemic strokes, when hemorrhagic stroke is ruled out, as defined by TOAST classification of subtypes of acute ischemic stroke. Aim 2: In cases of ischemic strokes of unknown or "cryptogenic" etiology, determine the ability of biomarker blood tests to predict etiology between cardioembolic and large artery atherosclerotic.

Ischemic StrokeIschemiaAtrial Fibrillation+14 more

Ischemia Care LLC500 participantsStarted Apr 2019

Columbus, Ohio, United States

Development of the Virtual Unified Huntington's Disease Rating Scale

Biomarkers of Acute Stroke in Clinic

Find Trials by Condition in Ohio

A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)

A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy

Immune Modulators for Treating COVID-19

Shwachman Diamond Syndrome Registry and Study

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Sinopsys Lacrimal Stent Study for Patients With Chronic Sinusitis or CRS

Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis

Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glycogen Storage Disease Type III

Study of Exchange of Travoprost Intraocular Implant

Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population